📣 VC round data is live. Check it out!
- Public Comps
- Remgro
Remgro Valuation Multiples
Discover Remgro's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Dongxing Securities, Changjiang Securities, Zheshang Securities, FUNO and more.
Remgro Overview
About Remgro
Remgro Ltd is an investment holding company with investments in the healthcare, consumer products, financial services, infrastructure, industrial, and media industries. Its segments include Consumer Products and Industrial and Other. It derives the majority of its revenue from Consumer Products.
Founded
1940
HQ

Employees
175
Website
Sectors
Financials (LTM)
EV
$6B
Valuation Multiples
Start free trialRemgro Financials
Remgro reported last 12-month revenue of $3B and EBITDA of $259M.
In the same LTM period, Remgro generated $1B in gross profit, $259M in EBITDA, and $610M in net income.
Revenue (LTM)
Remgro P&L
In the most recent fiscal year, Remgro reported revenue of $3B and EBITDA of $270M.
Remgro is profitable as of last fiscal year, with gross margin of 28%, EBITDA margin of 8%, and net margin of 14%.
Financial data powered by Morningstar, Inc.
Remgro Stock Performance
Remgro has current market cap of $6B, and enterprise value of $6B.
Market Cap Evolution
Remgro's stock price is $11.48.
Remgro share price decreased by 2.1% in the last 30 days, and increased by 21.2% in the last year.
Remgro has an EPS (earnings per share) of $0.82.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $6B | $6B | -2.0% | -2.1% | -0.3% | 21.2% | $0.82 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialRemgro Valuation Multiples
Remgro trades at 1.9x EV/Revenue multiple, and 22.1x EV/EBITDA.
EV / Revenue (LTM)
Remgro Financial Valuation Multiples
As of June 3, 2026, Remgro has market cap of $6B and EV of $6B.
Remgro has a P/E ratio of 10.5x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Remgro Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Remgro Margins & Growth Rates
In the most recent fiscal year, Remgro reported gross margin of 28%, EBITDA margin of 8%, and net margin of 14%.
Remgro Margins
Remgro Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Remgro Operational KPIs
Remgro's revenue per employee in the last FY averaged $18.6M, while opex per employee averaged $3.7M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Remgro Competitors
Remgro competitors include Dongxing Securities, Changjiang Securities, Zheshang Securities, FUNO, Zhongtai Securities, Kiwoom Securities, Macerich, Gecina, Aedifica and Cenergy Holdings.
Most Remgro public comparables operate across Asset Management.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 15.9x | - | - | - | |||
| 8.5x | 8.1x | - | - | |||
| 11.4x | 10.9x | - | - | |||
| 8.0x | 7.9x | 6.0x | 10.8x | |||
| 9.3x | - | - | - | |||
| 11.7x | 11.1x | - | - | |||
| 11.0x | 11.1x | 21.2x | 20.7x | |||
| 14.2x | 16.9x | 20.3x | 20.3x | |||
This data is available for Pro users. Sign up to see all Remgro competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Remgro
Remgro has acquired 2 companies to date.
Last acquisition by Remgro was on March 30th 2026. Remgro acquired Mediclinic Southern Africa for $950M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Remgro
| Description | Mediclinic Southern Africa operates private hospitals for multi-disciplinary acute care. | Mediclinic International is a Switzerland-headquartered private hospital group operating 73 facilities across three platforms. In Southern Africa, it runs 52 hospitals in South Africa and Namibia with 8,209 beds; in Switzerland through Hirslanden with 18 clinics and three hospitals; and in the UAE with 280 clinics and four hospitals. Employing 38,000 people, the group reported €4.4 billion in revenue for fiscal 2023 and serves over 10 million patients yearly, specializing in acute care across oncology, cardiology, neurosurgery, and maternity services. |
| HQ Country | ||
| HQ City | Vereeniging | Cape Town |
| Deal Date | 30 Mar 2026 | 4 Aug 2022 |
| Valuation | $950M | $8B |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Remgro acquisitions and their M&A valuation multiples. Start Free Trial | ||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Remgro
| When was Remgro founded? | Remgro was founded in 1940. |
| Where is Remgro headquartered? | Remgro is headquartered in South Africa. |
| How many employees does Remgro have? | As of today, Remgro has over 175 employees. |
| Who is the CEO of Remgro? | Remgro's CEO is Jannie Durand. |
| Is Remgro publicly listed? | Yes, Remgro is a public company listed on Johannesburg Stock Exchange. |
| What is the stock symbol of Remgro? | Remgro trades under REM ticker. |
| When did Remgro go public? | Remgro went public in 2000. |
| Who are competitors of Remgro? | Remgro main competitors include Dongxing Securities, Changjiang Securities, Zheshang Securities, FUNO, Zhongtai Securities, Kiwoom Securities, Macerich, Gecina, Aedifica, Cenergy Holdings. |
| What is the current market cap of Remgro? | Remgro's current market cap is $6B. |
| What is the current revenue of Remgro? | Remgro's last 12 months revenue is $3B. |
| What is the current EV/Revenue multiple of Remgro? | Current revenue multiple of Remgro is 1.9x. |
| What is the current EBITDA of Remgro? | Remgro's last 12 months EBITDA is $259M. |
| What is Remgro's EBITDA margin? | Remgro's last 12 months EBITDA margin is 9%. |
| What is the current EV/EBITDA multiple of Remgro? | Current EBITDA multiple of Remgro is 22.1x. |
| What is the current FCF of Remgro? | Remgro's last 12 months FCF is $276M. |
| What is Remgro's FCF margin? | Remgro's last 12 months FCF margin is 9%. |
| What is the current EV/FCF multiple of Remgro? | Current FCF multiple of Remgro is 20.8x. |
| How many companies Remgro has acquired to date? | As of June 2026, Remgro has acquired 2 companies. |
| What was the largest acquisition by Remgro? | $8B acquisition of Mediclinic International on 4th August 2022 was the largest M&A Remgro has done to date. |
| What companies Remgro acquired? | Remgro acquired Mediclinic International and Mediclinic Southern Africa. |
| In how many companies Remgro has invested to date? | Remgro hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Remgro
Lists including Remgro
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
